Unknown

Dataset Information

0

Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer.


ABSTRACT:

Purpose

We sought to determine the significant genomic alterations in patients with metastatic breast cancer (MBC), and survival outcomes in common genotypes.

Patients and methods

High-depth next generation sequencing was performed for 202 genes in tumor and normal DNA from 257 patients with MBC, including 165 patients with ER/PR+ HER2- (hormone receptor positive, HR+ positive), 32 patients with HER2+ and 60 patients with triple negative (ER/PR/HER2-) cancer. Kaplan Meier survival analysis was performed in our discovery set, in breast cancer patients analyzed in The Cancer Genome Atlas, and in a separate cohort of 98 patients with MBC who underwent clinical genomic testing.

Results

Significantly mutated genes (SMGs) varied by histology and tumor subtype, but TP53 was a SMG in all three subtypes. The most SMGs in HR+ patients included PIK3CA (32%), TP53 (29%), GATA3 (15%), CDH1 (8%), MAP3K1 (8%), PTEN (5%), TGFBR2 (4%), AKT1 (4%), and MAP2K4 (4%). TP53 mutations were associated with shorter recurrence-free survival (P=0.004), progression-free survival (P=0.00057) and overall survival (P=0.003). Further, TP53 status was prognostic among HR+ patients with PIK3CA mutations. TP53 mutations were also associated with poorer overall survival in the 442 HR+ breast cancer patients in the TCGA (P=0.042) and in an independent set of 96 HR+ MBC who underwent clinical sequencing (P=0.0004).

Conclusions

SMGs differ by tumor subtype but TP53 is significantly mutated in all three breast cancer subtypes. TP53 mutations are associated with poor prognosis in HR+ breast cancer. TP53 mutations should be considered in the design and interpretation of precision oncology trials.

SUBMITTER: Meric-Bernstam F 

PROVIDER: S-EPMC6050977 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6167800 | biostudies-other
| S-ECPF-GEOD-40954 | biostudies-other
| S-EPMC1929092 | biostudies-literature
2012-09-18 | E-GEOD-40954 | biostudies-arrayexpress
2012-09-18 | GSE40954 | GEO
| S-EPMC10092337 | biostudies-literature
| S-EPMC4203208 | biostudies-literature
| S-EPMC8530869 | biostudies-literature
| S-EPMC10741517 | biostudies-literature
| S-EPMC10620133 | biostudies-literature